Hanneke Later-Nijland

Dr. Hanneke M.J. Later-Nijland specialises in EU and Dutch regulatory life sciences law and has significant experience in both contentious and non-contentious work. Due to her dual background as a lawyer and a pharmacist, Hanneke is eminently qualified to handle the full range of issues relating to marketing authorisations, clinical trials (and agreements), compliance, issues with ATMPs, compounding, demarcation issues, advertising, administrative fines, reimbursement, financial arrangements, preference policy procedures and inspections - both human and veterinary medicinal products. Next to the aforementioned, she also worked on several large (medicina) cannabis cases.

Due to her background as an Inspector for Healthcare, she is often asked to interact with the various competent authorities in the Netherlands (e.g. CBG, IGJ, Ministry of Health, KNMP, NVWA), and/or the EMA, on behalf of her clients.

Furthermore, due to her scientific background, she works (with patent attorneys) on issues at the interface between genomics, regulatory and IP.

Hanneke’s mission is to advance transactions in the life sciences space by way of securing life sciences regulatory law as a building block in such transactions. Therefore, Hanneke has launched a network of corporate and regulatory lawyers focusing on life sciences transactions (www.thegenotypenetwork.com).

Hanneke obtained a MSc and PharmD in pharmacy (Utrecht, 2003 and 2004) as well as a Master of Law (LLM, Utrecht, 2006) and holds a PhD (Nijmegen, 2010) in pharmacy, which makes her the only pharmacist-lawyer holding a PhD in the Netherlands. She is admitted to the Bar of Amsterdam and allowed to practise throughout the Netherlands. Hanneke lectures pharmaceutical law at Leiden University and speaks regularly at (inter-)national conferences.

Hanneke founded Genome Lawyers in 2019, a boutique law firm in Amsterdam serving pharma and biotech clients across the globe, e.g. the US, Canada, Hong Kong, UK, Belgium, France, Germany, Italy and Japan.

Who’s Who Legal1 recommends Hanneke for Life Sciences: “Hanneke is singled out by market sources as a “very knowledgeable and pragmatic” practitioner who “really knows what she is talking about” thanks to her strong technical background in the life sciences arena.” Lastly, she is ranked in the upcoming edition of Chambers Europe 2024.